DE STEFANO, ALFONSO
 Distribuzione geografica
Continente #
AS - Asia 1.012
EU - Europa 975
NA - Nord America 922
SA - Sud America 141
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.100
Nazione #
US - Stati Uniti d'America 885
SG - Singapore 567
RU - Federazione Russa 516
CN - Cina 236
IT - Italia 132
BR - Brasile 109
DE - Germania 73
HK - Hong Kong 72
VN - Vietnam 72
NL - Olanda 63
FI - Finlandia 56
IE - Irlanda 38
UA - Ucraina 36
CA - Canada 28
CI - Costa d'Avorio 28
GB - Regno Unito 20
IN - India 17
JP - Giappone 15
AR - Argentina 13
SE - Svezia 12
ZA - Sudafrica 12
MX - Messico 8
EC - Ecuador 7
FR - Francia 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
BD - Bangladesh 4
BE - Belgio 4
TR - Turchia 4
BG - Bulgaria 3
PE - Perù 3
PL - Polonia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
ID - Indonesia 2
LT - Lituania 2
PH - Filippine 2
SA - Arabia Saudita 2
AT - Austria 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.100
Città #
Singapore 270
Moscow 119
Chandler 112
Beijing 111
Ashburn 88
Hong Kong 72
Amsterdam 58
Santa Clara 52
Munich 47
San Jose 44
Millbury 35
Los Angeles 31
Princeton 29
Hanoi 23
Napoli 23
Ho Chi Minh City 20
Nanjing 20
Naples 19
New York 19
Turku 19
Boston 16
Ottawa 16
São Paulo 14
Tokyo 14
Buffalo 11
Brooklyn 10
Dallas 9
Des Moines 9
Lentini 9
Nanchang 9
Redondo Beach 9
Denver 8
Helsinki 8
London 8
Shenyang 8
Tianjin 8
Casoria 6
Chicago 6
Frankfurt am Main 6
Jiaxing 6
Mexico City 6
Wilmington 6
Atlanta 5
Guayaquil 5
Houston 5
Milan 5
Olomouc 5
Seattle 5
Washington 5
Chennai 4
Falkenstein 4
Indiana 4
Jacksonville 4
Montreal 4
Poplar 4
San Francisco 4
The Dalles 4
Guarulhos 3
Haiphong 3
Hefei 3
Ipatinga 3
Johannesburg 3
Lima 3
Orem 3
Phoenix 3
Toronto 3
Acerra 2
Afragola 2
Annapolis 2
Augusta 2
Belo Horizonte 2
Belém 2
Boardman 2
Courcelles 2
Da Nang 2
Edegem 2
Fortaleza 2
Goiânia 2
Guangzhou 2
Hicksville 2
Jaú 2
Jeddah 2
Manchester 2
Medellín 2
Messina 2
Mumbai 2
New Delhi 2
Ninh Bình 2
Norwalk 2
Nuremberg 2
Praia Grande 2
Pune 2
Redwood City 2
Samarkand 2
San Mateo 2
Stockholm 2
São Bernardo do Campo 2
São José do Rio Preto 2
Villarosa 2
Warsaw 2
Totale 1.575
Nome #
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 156
STATO DELL'ARTE SULLA CHEMIOTERAPIA NEL CANCRO DEL COLON 148
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer 142
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 131
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 127
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 125
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 123
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools 119
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 119
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 119
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 112
Double complete response in MCRC patient 109
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 105
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors. 104
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 100
Bevacizumab as 4th line treatment in metastatic colorectal cancer 99
Neoadjuvant treatment with capecitabine and oxaliplatin in combination with radiotherapy for rectal cancer patients: a phase II study 97
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS 97
Bevacizumab related arterial hypertension as a predictive marker in metastatic Colorectal Cancer (mCRC) patients 94
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer 94
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? 94
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 90
Correlation between bevacizumab-related hypertension and response in mCRC patients 89
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 88
Bevacizumab maintenance in metastatic colorectal cancer: How long? 85
Surgery in lung cancer metastasis 84
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer 83
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer 79
Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer 75
Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015) 59
Totale 3.146
Categoria #
all - tutte 10.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 9 4 11 2 6 2
2021/2022221 3 1 2 4 1 11 1 7 48 23 47 73
2022/2023284 31 15 9 19 29 31 0 30 45 59 13 3
2023/2024166 4 27 29 13 6 19 0 29 0 1 22 16
2024/2025997 42 43 4 11 31 59 89 57 54 77 457 73
2025/20261.172 200 95 172 173 376 79 77 0 0 0 0 0
Totale 3.146